Sun Pharmaceutical Industries declined 2.68% to Rs 1746.95 after the company announced that the US FDA, post an audit, has determined the Baska facility inspection classification as Official Action ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback